Octapharma USA, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13.7M | 1,888 | 77.8% |
| Honoraria | $1.2M | 434 | 6.6% |
| Grant | $885,287 | 10 | 5.0% |
| Travel and Lodging | $651,481 | 1,239 | 3.7% |
| Food and Beverage | $622,832 | 19,300 | 3.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $437,220 | 15 | 2.5% |
| Consulting Fee | $140,954 | 154 | 0.8% |
| Education | $3,150 | 34 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Von Willebrand Factor in Pregnancy (VIP) Study | $2.0M | 0 | 2 |
| GAM10-10 | $1.2M | 3 | 67 |
| NGAM-13 | $1.2M | 8 | 106 |
| INdividualized ITI based on fviii ATE protection by vwf INITIATE | $1.1M | 0 | 1 |
| GAM5-28 | $1.0M | 2 | 331 |
| LEX-211 | $1.0M | 4 | 30 |
| GAM10-08 | $880,249 | 8 | 204 |
| SCGAM-06 | $683,480 | 7 | 178 |
| LEX-209 | $452,610 | 11 | 196 |
| NORM-01 | $383,258 | 1 | 70 |
| NGAM-12 | $348,562 | 4 | 117 |
| LEX-210 | $329,999 | 1 | 35 |
| Von Willebrand Factor in Pregnancy | $329,662 | 0 | 8 |
| SCGAM-03 | $319,159 | 4 | 51 |
| NGAM-10 | $241,150 | 3 | 77 |
| SCGAM-01 | $193,594 | 0 | 32 |
| LAS-215 | $176,936 | 3 | 31 |
| LAS-213 | $161,157 | 5 | 45 |
| CUTAQUIG REGISTRY | $151,582 | 0 | 3 |
| Gena-21b | $120,638 | 0 | 45 |
| Cutaquig Registry | $119,129 | 0 | 1 |
| Gena-05 | $118,264 | 0 | 29 |
| PPH STUDY | $114,955 | 0 | 3 |
| ATN-106 | $105,448 | 1 | 9 |
| GENA-21b | $102,902 | 0 | 16 |
| LAS-212 | $86,005 | 4 | 24 |
| PANS STUDY | $81,078 | 0 | 2 |
| NGAM-11 | $67,223 | 7 | 18 |
| OCTAPLAS IIS STUDY | $62,165 | 0 | 4 |
| GENA-05 | $52,387 | 5 | 30 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Shawn Jobe, M.d, M.D | Pediatric Hematology-Oncology | Lansing, MI | $30,877 | $0 |
| James Seibold, Md, MD | Rheumatology | Farmington, CT | $30,300 | $0 |
| Dr. Ryan Metcalf, M.d, M.D | Anatomic Pathology & Clinical Pathology | Seattle, WA | $30,000 | $0 |
| David Cornblath, M.d, M.D | Neurology | Lutherville, MD | $29,118 | $0 |
| Mr. Nathanael Brady, D.o, D.O | Allergy & Immunology | Colorado Springs, CO | $28,923 | $0 |
| Tammuella Chrisentery-Singleton, Md, MD | Pediatric Hematology-Oncology | New Orleans, LA | $26,917 | $0 |
| Jerrold Levy, Md, MD | Anesthesiology | Durham, NC | $25,131 | $0 |
| David Fiorentino, Md, MD | Dermatology | Stanford, CA | $24,625 | $0 |
| Dr. Nathan Connell, Md, Mph, MD, MPH | Hematology | Boston, MA | $24,079 | $0 |
| Dr. Jonathan Roberts, M.d, M.D | Pediatrics | Peoria, IL | $23,838 | $0 |
| George Sakoulas, Md, MD | Infectious Disease | San Diego, CA | $22,374 | $0 |
| Victoria Werth, Md, MD | Dermatology | Philadelphia, PA | $21,802 | $0 |
| Jennifer Davila, Md, MD | Pediatrics | Bronx, NY | $21,343 | $0 |
| Spencer Sullivan, Md, MD | Pediatric Hematology-Oncology | Madison, MS | $21,046 | $0 |
| Lisa Christopher, M.d, M.D | Rheumatology | Baltimore, MD | $20,258 | $0 |
| Dr. Stacy Croteau, Md, MD | Pediatric Hematology-Oncology | Boston, MA | $18,807 | $0 |
| Akshat Jain, Md, MD | Pediatric Hematology-Oncology | Redlands, CA | $18,181 | $0 |
| Dr. Catherine Mcguinn, M.d, M.D | Pediatric Hematology-Oncology | New York, NY | $17,961 | $0 |
| Dr. Carolyn Burns, Md, MD | Anatomic Pathology & Clinical Pathology | Louisville, KY | $17,902 | $0 |
| Dr. Shveta Gupta, M.d, M.D | Pediatrics | Orlando, FL | $17,307 | $0 |
| Dr. Guillermo De Angulo, Md, MD | Pediatric Hematology-Oncology | Miami, FL | $16,910 | $0 |
| Dr. Manish Butte, M.d., Ph.d, M.D., PH.D | Allergy & Immunology | Los Angeles, CA | $15,883 | $0 |
| Dr. Marinos Dalakas, Md, MD | Neurology | Philadelphia, PA | $15,792 | $0 |
| Julie Jaffray, M.d, M.D | Pediatric Hematology-Oncology | San Diego, CA | $15,378 | $0 |
| Tjorvi Perry, M.d, M.D | Anesthesiology | Minneapolis, MN | $14,955 | $0 |
Top Products
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) $2.9M
- OCTAGAM IMMUNE GLOBULIN (HUMAN) $2.4M
Associated Products (14)
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) $2.9M
- OCTAGAM IMMUNE GLOBULIN (HUMAN) $2.8M
- PANZYGA $2.5M
- WILATE $2.0M
- CUTAQUIG $1.6M
- OCTAGAM $1.4M
- NUWIQ $1.1M
- OCTAPLAS $560,635
- FIBRYGA $418,333
- OCTAPLEX $400,900
- OCTANORM $341,872
- CUTAQUIQ $82,876
- BALFAXAR $49,885
- IVIG $29,114
Payment Categories
- Food & Beverage $622,832
- Consulting $140,954
- Travel & Lodging $651,481
- Research $13.7M
About Octapharma USA, Inc.
Octapharma USA, Inc. has made $17.6M in payments to 7,638 healthcare providers, recorded across 23,074 transactions in the CMS Open Payments database. In 2024, the company paid $1.8M. The top product by payment volume is WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) ($2.9M).
Payments were distributed across 166 medical specialties. The top specialty by payment amount is Pediatric Hematology-Oncology ($603,018 to 125 doctors).
Payment categories include: Food & Beverage ($622,832), Consulting ($140,954), Research ($13.7M), Travel & Lodging ($651,481).
Octapharma USA, Inc. is associated with 14 products in the CMS Open Payments database, including WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN), OCTAGAM IMMUNE GLOBULIN (HUMAN), and PANZYGA.